-
1
-
-
79955015634
-
A predictive model for progression of chronic kidney disease to kidney failure
-
Tangri N, Stevens LA, Griffith J et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305: 1553-1557
-
(2011)
JAMA
, vol.305
, pp. 1553-1557
-
-
Tangri, N.1
Stevens, L.A.2
Griffith, J.3
-
2
-
-
80051569374
-
GFR decline and mortality risk among patients with chronic kidney disease
-
Perkins RM, Bucaloiu ID, Kirchner HL et al. GFR decline and mortality risk among patients with chronic kidney disease. Clin J Am Soc Nephrol 2011; 6: 1879-1886
-
(2011)
Clin J Am Soc Nephrol
, vol.6
, pp. 1879-1886
-
-
Perkins, R.M.1
Bucaloiu, I.D.2
Kirchner, H.L.3
-
3
-
-
4644221457
-
Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization
-
Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. N Engl J Med 2004; 351: 1296-1305
-
(2004)
N Engl J Med
, vol.351
, pp. 1296-1305
-
-
Go, A.S.1
Chertow, G.M.2
Fan, D.3
-
4
-
-
1942506539
-
Chronic Kidney Disease as a Risk Factor for Cardiovascular Disease and All-Cause Mortality: A Pooled Analysis of Community-Based Studies
-
DOI 10.1097/01.ASN.0000123691.46138.E2
-
Weiner DE,Tighiouart H,AminMGet al.Chronickidneydiseaseas a risk factor for cardiovascular disease and all-causemortality: a pooled analysis of community-based studies.J Am Soc Nephrol.2004.15.1307-1315. (Pubitemid 38526012)
-
(2004)
Journal of the American Society of Nephrology
, vol.15
, Issue.5
, pp. 1307-1315
-
-
Weiner, D.E.1
Tighiouart, H.2
Amin, M.G.3
Stark, P.C.4
Macleod, B.5
Griffith, J.L.6
Salem, D.N.7
Levey, A.S.8
Sarnak, M.J.9
-
5
-
-
79957827666
-
Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease.A collaborative meta-analysis of kidney disease population cohorts
-
Astor BA, Matsushita K, Gansevoort RT et al. Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts. Kidney Int 2011; 79: 1331-1340
-
(2011)
Kidney Int
, vol.79
, pp. 1331-1340
-
-
Astor, B.A.1
Matsushita, K.2
Gansevoort, R.T.3
-
6
-
-
79958811114
-
The definition, classification, and prognosis of chronic kidney disease: A KDIGO Controversies Conference report
-
Levey AS, de Jong PE, Coresh J et al. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int 2011; 80: 17-28
-
(2011)
Kidney Int
, vol.80
, pp. 17-28
-
-
Levey, A.S.1
De Jong, P.E.2
Coresh, J.3
-
7
-
-
52049096629
-
Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort
-
Levin A, Djurdjev O, BeaulieuMet al. Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort. Am J Kidney Dis 2008; 52: 661-671
-
(2008)
Am J Kidney Dis
, vol.52
, pp. 661-671
-
-
Levin, A.1
Djurdjev, O.2
Beaulieu, M.3
-
8
-
-
56649086676
-
Guidelines for the management of chronic kidney disease
-
Levin A, Hemmelgarn B, Culleton B et al. Guidelines for the management of chronic kidney disease. CMAJ 2008; 179: 1154-1162
-
(2008)
CMAJ
, vol.179
, pp. 1154-1162
-
-
Levin, A.1
Hemmelgarn, B.2
Culleton, B.3
-
9
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation classification, and stratification
-
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.AmJKidneyDis 2002; 39: S1-S266
-
(2002)
Am J Kidney Dis
, vol.39
-
-
-
10
-
-
75849147039
-
Relation between kidney function, proteinuria, and adverse outcomes
-
Hemmelgarn BR, Manns BJ, Lloyd A et al. Relation between kidney function, proteinuria, and adverse outcomes. JAMA 2010; 303: 423-429
-
(2010)
JAMA
, vol.303
, pp. 423-429
-
-
Hemmelgarn, B.R.1
Manns, B.J.2
Lloyd, A.3
-
11
-
-
35848968871
-
Prevalence of chronic kidney disease in the United States
-
DOI 10.1001/jama.298.17.2038
-
Coresh J, Selvin E, Stevens LA et al. Prevalence of chronic kidney disease in the United States. JAMA 2007; 298: 2038-2047 (Pubitemid 350074801)
-
(2007)
Journal of the American Medical Association
, vol.298
, Issue.17
, pp. 2038-2047
-
-
Coresh, J.1
Selvin, E.2
Stevens, L.A.3
Manzi, J.4
Kusek, J.W.5
Eggers, P.6
Van Lente, F.7
Levey, A.S.8
-
12
-
-
0035127168
-
Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency
-
Tonelli M, Bohm C, Pandeya S et al. Cardiac risk factors and the use of cardioprotective medications in patients with chronic renal insufficiency. Am J Kidney Dis 2001; 37: 484-489 (Pubitemid 32195286)
-
(2001)
American Journal of Kidney Diseases
, vol.37
, Issue.3
, pp. 484-489
-
-
Tonelli, M.1
Bohm, C.2
Pandeya, S.3
Gill, J.4
Levin, A.5
Kiberd, B.A.6
-
13
-
-
1642413198
-
Longitudinal Follow-up and Outcomes among a Population with Chronic Kidney Disease in a Large Managed Care Organization
-
DOI 10.1001/archinte.164.6.659
-
Keith DS, Nichols GA, Gullion CM et al. Longitudinal follow-up and outcomes among a population with chronic kidney disease in a large managed care organization. Arch Intern Med 2004; 164: 659-663 (Pubitemid 38392981)
-
(2004)
Archives of Internal Medicine
, vol.164
, Issue.6
, pp. 659-663
-
-
Keith, D.S.1
Nichols, G.A.2
Gullion, C.M.3
Brown, J.B.4
Smith, D.H.5
-
14
-
-
20044364822
-
Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000
-
DOI 10.1681/ASN.2004070539
-
Coresh J, Byrd-Holt D, Astor BC et al. Chronic kidney disease awareness, prevalence, and trends among U.S. adults, 1999 to 2000. J Am Soc Nephrol 2005; 16: 180-188 (Pubitemid 43073171)
-
(2005)
Journal of the American Society of Nephrology
, vol.16
, Issue.1
, pp. 180-188
-
-
Coresh, J.1
Byrd-Holt, D.2
Astor, B.C.3
Briggs, J.P.4
Eggers, P.W.5
Lacher, D.A.6
Hostetter, T.H.7
-
15
-
-
42449159875
-
Limited knowledge of kidney disease in a survey of AusDiab study participants
-
White SL, Polkinghorne KR, Cass A et al. Limited knowledge of kidney disease in a survey of AusDiab study participants. Med J Aust 2008; 188: 204-208
-
(2008)
Med J Aust
, vol.188
, pp. 204-208
-
-
White, S.L.1
Polkinghorne, K.R.2
Cass, A.3
-
16
-
-
27844597274
-
Barriers to successful care for chronic kidney disease
-
Lenz O, Mekala DP, Patel DV et al. Barriers to successful care for chronic kidney disease. BMC Nephrol 2005; 6: 11 17.
-
(2005)
BMC Nephrol
, vol.6
, pp. 1117
-
-
Lenz, O.1
Mekala, D.P.2
Patel, D.V.3
-
17
-
-
34347334551
-
Chronic kidney disease management in the United Kingdom: NEOERICA project results
-
DOI 10.1038/sj.ki.5002273, PII 5002273
-
Stevens PE, O'Donoghue DJ, de Lusignan S et al. Chronic kidney disease management in the United Kingdom: NEOERICA project results. Kidney Int 2007; 72: 92-99 (Pubitemid 47014451)
-
(2007)
Kidney International
, vol.72
, Issue.1
, pp. 92-99
-
-
Stevens, P.E.1
O'Donoghue, D.J.2
De Lusignan, S.3
Van Vlymen, J.4
Klebe, B.5
Middleton, R.6
Hague, N.7
New, J.8
Farmer, C.K.T.9
-
20
-
-
38049096095
-
The meaning of translational research and why it matters
-
Woolf SH. The meaning of translational research and why it matters. JAMA 2008; 299: 211-213
-
(2008)
JAMA
, vol.299
, pp. 211-213
-
-
Woolf, S.H.1
-
21
-
-
79959746706
-
On behalf of the SHARP Investigators.The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): Randomised placebo-controlled trial
-
Baigent C, Landray MJ, Reith C et al. on behalf of the SHARP Investigators. The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): randomised placebo-controlled trial. Lancet 2011; 377: 2181-2192
-
(2011)
Lancet
, vol.377
, pp. 2181-2192
-
-
Baigent, C.1
Landray, M.J.2
Reith, C.3
|